Literature DB >> 2508535

Tau in situ hybridization in normal and Alzheimer brain: localization in the somatodendritic compartment.

K S Kosik1, J E Crandall, E J Mufson, R L Neve.   

Abstract

Tau messenger RNA in situ hybridization in human postmortem brain revealed that neurons are the predominant cell type labeled. The probe used includes the nucleotide sequence coding for the amino acids recognized by the well-characterized tau monoclonal antibodies 5E2 and tau 1. The distribution of the tau RNA is abundant throughout the neuronal somata and into the proximal parts of dendrites of pyramidal cells in the cerebral cortex and the hippocampus. The distal extent to which silver grains could be visualized in the pyramidal cell dendrite was comparable to that seen with a probe to ribosomal RNA. In contrast to the tau probe the ribosomal probe also labeled glial cells. Sections hybridized with the tau probe and then double-labeled with thioflavine S revealed that neurons containing neurofibrillary tangles continue to synthesize tau protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508535     DOI: 10.1002/ana.410260308

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  24 in total

1.  The EF-hand Ca(2+)-binding protein p22 associates with microtubules in an N-myristoylation-dependent manner.

Authors:  S Timm; B Titus; K Bernd; M Barroso
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

Review 2.  Analysis of subcellularly localized mRNAs using in situ hybridization, mRNA amplification, and expression profiling.

Authors:  James Eberwine; Brian Belt; Janet Estee Kacharmina; Kevin Miyashiro
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  Massive accumulation of modified tau and severe depletion of normal tau characterize the cerebral cortex and white matter of Alzheimer's disease. Demonstration using the hydrated autoclaving method.

Authors:  R W Shin; T Iwaki; T Kitamoto; Y Sato; J Tateishi
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

4.  Increased tau messenger RNA in Alzheimer's disease hippocampus.

Authors:  A J Barton; P J Harrison; A Najlerahim; J Heffernan; B McDonald; J R Robinson; D C Davies; W J Harrison; P Mitra; J A Hardy
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

5.  Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation.

Authors:  Chuanzhou Li; Jürgen Götz
Journal:  EMBO J       Date:  2017-09-01       Impact factor: 11.598

6.  Axonal regeneration. Systemic administration of epothilone B promotes axon regeneration after spinal cord injury.

Authors:  Jörg Ruschel; Farida Hellal; Kevin C Flynn; Sebastian Dupraz; David A Elliott; Andrea Tedeschi; Margaret Bates; Christopher Sliwinski; Gary Brook; Kristina Dobrindt; Michael Peitz; Oliver Brüstle; Michael D Norenberg; Armin Blesch; Norbert Weidner; Mary Bartlett Bunge; John L Bixby; Frank Bradke
Journal:  Science       Date:  2015-03-12       Impact factor: 47.728

7.  Pathological missorting of endogenous MAPT/Tau in neurons caused by failure of protein degradation systems.

Authors:  Varun Balaji; Senthilvelrajan Kaniyappan; Eckhard Mandelkow; Yipeng Wang; Eva-Maria Mandelkow
Journal:  Autophagy       Date:  2018-09-13       Impact factor: 16.016

8.  Gene Therapy Models of Alzheimer's Disease and Other Dementias.

Authors:  Benjamin Combs; Andrew Kneynsberg; Nicholas M Kanaan
Journal:  Methods Mol Biol       Date:  2016

Review 9.  Tau function and dysfunction in neurons: its role in neurodegenerative disorders.

Authors:  Jesús Avila; Filip Lim; Francisco Moreno; Carlos Belmonte; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

Review 10.  Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors:  Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.